NCT00071227View on ClinicalTrials.gov

Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 15, 2003

Study Completion Date

August 15, 2007

Conditions
Macular DegenerationRetinal Vein Occlusion
Interventions
DRUG

Triamcinolone Acetonide (TAC-PF)

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00071227 - Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders | Biotech Hunter | Biotech Hunter